Literature DB >> 25849780

Iron oxide nanorods as high-performance magnetic resonance imaging contrast agents.

Jeotikanta Mohapatra1, Arijit Mitra, Himanshu Tyagi, D Bahadur, M Aslam.   

Abstract

An efficient magnetic resonance imaging (MRI) contrast agent with a high R2 relaxivity value is achieved by controlling the shape of iron oxide to rod like morphology with a length of 30-70 nm and diameter of 4-12 nm. Fe3O4 nanorods of 70 nm length, encapsulated with polyethyleneimine show a very high R2 relaxivity value of 608 mM(-1) s(-1). The enhanced MRI contrast of nanorods is attributed to their higher surface area and anisotropic morphology. The higher surface area induces a stronger magnetic field perturbation over a larger volume more effectively for the outer sphere protons. The shape anisotropy contribution is understood by calculating the local magnetic field of nanorods and spherical nanoparticles under an applied magnetic field (3 Tesla). As compared to spherical geometry, the induced magnetic field of a rod is stronger and hence the stronger magnetic field over a large volume leads to a higher R2 relaxivity of nanorods.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25849780     DOI: 10.1039/c5nr00055f

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  22 in total

1.  Shape-Dependent Relaxivity of Nanoparticle-Based T1 Magnetic Resonance Imaging Contrast Agents.

Authors:  Kayla S B Culver; Yu Jin Shin; Matthew W Rotz; Thomas J Meade; Mark C Hersam; Teri W Odom
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2016-09-13       Impact factor: 4.126

2.  Fe/Mn Multilayer Nanowires as High-Performance T1-T2 Dual Modal MRI Contrast Agents.

Authors:  Xiaoming Cao; Liyuan Gu; Shike Hu; Aiman Mukhtar; Kaiming Wu
Journal:  Materials (Basel)       Date:  2021-04-27       Impact factor: 3.623

3.  An immunochromatography strip with peroxidase-mimicking ferric oxyhydroxide nanorods-mediated signal amplification and readout.

Authors:  Dong Yang; Lei Lei; Kaidi Yang; Keyi Gao; Tongtong Jia; Lixia Wang; Xue Wang; Chaohua Xue
Journal:  Mikrochim Acta       Date:  2022-01-11       Impact factor: 5.833

Review 4.  Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Dalong Ni; Wenbo Bu; Emily B Ehlerding; Weibo Cai; Jianlin Shi
Journal:  Chem Soc Rev       Date:  2017-11-27       Impact factor: 54.564

5.  Synthesis and characterization of ZnFe2O4 nanoparticles and its biomedical applications.

Authors:  S Manjura Hoque; Md Sazzad Hossain; Shamima Choudhury; S Akhter; F Hyder
Journal:  Mater Lett       Date:  2016-02-01       Impact factor: 3.423

Review 6.  Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives.

Authors:  Mike Jeon; Mackenzie V Halbert; Zachary R Stephen; Miqin Zhang
Journal:  Adv Mater       Date:  2020-06-04       Impact factor: 32.086

7.  Morphologically controlled synthesis of ferric oxide nano/micro particles and their catalytic application in dry and wet media: a new approach.

Authors:  Muhammad Ramzan Saeed Ashraf Janjua; Saba Jamil; Nazish Jahan; Shanza Rauf Khan; Saima Mirza
Journal:  Chem Cent J       Date:  2017-05-31       Impact factor: 4.215

8.  Synthesis of manganese doped β-FeOOH and MnFe2O4 nanorods for enhanced drug delivery and hyperthermia application.

Authors:  Chandunika R K; Vijayaraghavan Rajagopalan; Niroj Kumar Sahu
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

Review 9.  Iron Oxide as an MRI Contrast Agent for Cell Tracking.

Authors:  Daniel J Korchinski; May Taha; Runze Yang; Nabeela Nathoo; Jeff F Dunn
Journal:  Magn Reson Insights       Date:  2015-10-06

10.  One-Step Facile Synthesis of Highly Magnetic and Surface Functionalized Iron Oxide Nanorods for Biomarker-Targeted Applications.

Authors:  Anamaria Orza; Hui Wu; Yaolin Xu; Qiong Lu; Hui Mao
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-06       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.